Showing results (31-40 of 149) with videos related to
Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2019
Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective StudyMattia Boeri, Massimo Milione, Claudia Proto, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2016
Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening ParticipantsUgo Pastorino, Roberto Boffi, Alfonso Marchianò, et al.Tumori|November 12, 2020
Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in ItalyGiovanni Apolone, Emanuele Montomoli, Alessandro Manenti, et al.Cancers|July 11, 2020
Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture AnalysisMassimo Milione, Mattia Boeri, Anna Cantarutti, et al.Journal of Cellular Biochemistry|August 28, 2007
The role of chromosomal alterations in human cancer developmentPatrizia Gasparini, Gabriella Sozzi, Marco A PierottiJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 31, 2022
Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening TrialUgo Pastorino, Vito Ladisa, Sara Trussardo, et al.Cells|January 26, 2019
Tumor Extracellular Matrix Remodeling: New Perspectives as a Circulating Tool in the Diagnosis and Prognosis of Solid TumorsMarta Giussani, Tiziana Triulzi, Gabriella Sozzi, et al.European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
Prognostic determinants in epithelioid sarcomaPatrizia Gasparini, Federica Facchinetti, Mattia Boeri, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 22, 2021
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based TreatmentsCristina Borzi, Monica Ganzinelli, Elisa Caiola, et al.Translational Lung Cancer Research|July 18, 2020
Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score systemArsela Prelaj, Claudia Proto, Giuseppe Lo Russo, et al.Pageof 15